Lupin launches pain relieving generic tablets in US
Lupin's product is a generic version of Allergan Sales LLC's Norco tablets in the same strengths and is indicated for relief of moderate to moderately severe pain.
By PTI | Updated:
NEW DELHI: Drug firm Lupin today said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market.
The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin said in a BSE filing.
The company's product is a generic version of Allergan Sales LLC's Norco tablets in the same strengths and is indicated for relief of moderate to moderately severe pain, it added.
As per IMS MAT June 2017 data, Hydrocodone Bitartrate and Acetaminophen tablets had annual sales of around USD 710 million.
Shares of Lupin today closed 1.99 per cent higher at Rs 1,060.50 per scrip on BSE.
The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin said in a BSE filing.
The company's product is a generic version of Allergan Sales LLC's Norco tablets in the same strengths and is indicated for relief of moderate to moderately severe pain, it added.
As per IMS MAT June 2017 data, Hydrocodone Bitartrate and Acetaminophen tablets had annual sales of around USD 710 million.
Shares of Lupin today closed 1.99 per cent higher at Rs 1,060.50 per scrip on BSE.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
